Vulnerability · Published Jun 24, 2022 · Assigned by icscert
CVE-2022-15213.2.4 IMPROPER ACCESS CONTROL CWE-284
Critical 9.1
In plain English
A critical-severity improper access control in iSeq 100 Instrument from Illumina. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 1.1% (higher than 67% of all known vulnerabilities).
Severity (CVSS 3.1)9.1Critical
Exploit odds (30 days)1.1%top 33.2% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Illumina | NextSeq 550Dx | LRM Versions 1.3 to 3.1 |
| Illumina | MiSeq Dx | LRM Versions 1.3 to 3.1 |
| Illumina | NextSeq 500 Instrumen | LRM Versions 1.3 to 3.1 |
| Illumina | NextSeq 550 Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | MiSeq Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | iSeq 100 Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | MiniSeq Instrument | LRM Versions 1.3 to 3.1 |
Weakness: CWE-284 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02 x_refsource_MISC